Newfin Pharmaceuticals Private Limited
Founded in 1996 and headquartered in Telangana, India.
1996 | Kukatpally Hyderabad, Telangana (India) | Active
Newfin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 29 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth -25.37%
- Profit Growth -1485.30%
- Ebitda -117.38%
- Net Worth -5.17%
- Total Assets -30.74%
About Newfin Pharmaceuticals
Newfin Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 1996 and has a history of 29 years and one month. Its registered office is in Kukatpally, Hyderabad, Telangana.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.00 M.
Suresh Adapa and Tamma Rani serve as directors at the Company.
Company Details
- Location Kukatpally, Hyderabad, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG1996PTC022898
- Company No.
022898
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals
Who are the key members and board of directors at Newfin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Adapa  | Additional Director | 25-Aug-2015 | Current |
| Tamma Rani | Additional Director | 01-Jul-2016 | Current |
Financial Performance of Newfin Pharmaceuticals.
Newfin Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 25.37% decrease. The company also saw a substantial fall in profitability, with a 1485.3% decrease in profit. The company's net worth dipped by a decrease of 5.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newfin Pharmaceuticals?
In 2017, Newfin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aushadi Health Care Private Limited
Suresh Adapa is a mutual person
Charges (Loans)
Open Charges
₹3.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Sbi : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2003 | Sbi | ₹1.00 M | Open |
| 02 Dec 1996 | Sbi | ₹2.00 M | Open |
How Many Employees Work at Newfin Pharmaceuticals?
Unlock and access historical data on people associated with Newfin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newfin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newfin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Newfin Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Newfin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Newfin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Tamma Sandhya Rani was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2016 & has been associated with this company since 8 years 8 months .
- Director Appointment
Suresh Adapa was appointed as a Additional Director was appointed as a Additional Director on 25 Aug 2015 & has been associated with this company since 9 years 6 months .
- Charges
A charge with Sbi amounted to Rs. 1.00 M with Charge ID 90117840 was registered on 24 Jul 2003.
- Charges
A charge with Sbi amounted to Rs. 2.00 M with Charge ID 90117177 was registered on 02 Dec 1996.
Frequently asked questions
What is the Incorporation or founding date of Newfin Pharmaceuticals Private Limited?
Newfin Pharmaceuticals Private Limited was incorporated on 17 Jan 1996.
What is authorized share capital and paid-up capital of Newfin Pharmaceuticals Private Limited?
The authorized share capital of Newfin Pharmaceuticals Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.50 M.
Who are the current board members & directors of Newfin Pharmaceuticals Private Limited?
Currently 2 directors are associated with Newfin Pharmaceuticals Private Limited.
- Suresh Adapa
- Tamma Sandhya Rani
What is the registered address of Newfin Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Newfin Pharmaceuticals Private Limited is 6-3 Sterling Emerald Plot No.118 Bhagyanagar Colony, India, Kukatpally Hyderabad, Telangana.
What is the corporate identification number (CIN) and company number of Newfin Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Newfin Pharmaceuticals Private Limited is U24239TG1996PTC022898 and the company number is 022898 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Newfin Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for Newfin Pharmaceuticals Private Limited has fallen by -25.37%.
What change has been observed in the net worth of Newfin Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Newfin Pharmaceuticals Private Limited has experienced an downturn of -5.17%.
What are the total open charges for Newfin Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2017, The total open charges for Newfin Pharmaceuticals Private Limited amount to ₹ 3.00 M.
When was the last Balance Sheet of Newfin Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Newfin Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
BR
Bonthu ReddyDirectorGK
Guntaka KumarDirectorKK
Konda KishoreManaging DirectorAR
Arumalla ReddyDirectorBA
Bonthu ArunaDirector